Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02132949
Brief Title: A Study Evaluating Pertuzumab (Perjeta) Combined With Trastuzumab (Herceptin) and Standard Anthracycline-based Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced, Inflammatory, or Early-stage Breast Cancer

First Submitted : May 6, 2014
First Submitted that Met QC Criteria : May 6, 2014
First Posted : May 7, 2014 (Estimate)

Results First Submitted : March 1, 2017
Results First Submitted that Met QC Criteria : March 1, 2017
Results First Posted : April 13, 2017

Last Update Submitted that Met QC Criteria : October 22, 2019
Last Update Posted : October 24, 2019